3-hydroxybenzaldehyde | CAS:100-83-4

We serve 3-hydroxybenzaldehyde CAS:100-83-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-hydroxybenzaldehyde

Chemical Name:3-hydroxybenzaldehyde
CAS.NO:100-83-4
Synonyms:3-hydroxybenzaldehyde
m-hydroxy-benzaldehyd
m-Aldehydophenol
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 240.9±13.0 °C at 760 mmHg
Melting Point 100-103 °C(lit.)
Molecular Formula C7H6O2
Molecular Weight 122.121
Flash Point 98.6±12.4 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.618
 
Specification:
Appearance:White to yellow powder
Assay:≥98.0%
Moisture:≤0.5%
Melting Point:100-105°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Quinine(CAS:130-95-0).



Contact us for information like 3-hydroxybenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-Aldehydophenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-Aldehydophenol Use and application,m-Aldehydophenol technical grade,usp/ep/jp grade.


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.p-Anisidine manufacturer A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.(1S,3S,5S)-tert-Butyl 3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate supplier A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.Pivaloyl chloride vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.